Undesirable properties of rubella vaccines with special reference to their use in women of fertile age.
D000818:Animals; D000914:Antibodies, Viral; D002584:Cervix Uteri / Q000382:microbiology; D002986:Clinical Trials as Topic; D004285:Dogs / Q000276:immunology; D004372:Ducks / Q000276:immunology; D004622:Embryo, Mammalian / Q000276:immunology; D004625:Embryo, Nonmammalian; D005260:Female; D005333:Fetus / Q000276:immunology* / Q000382:microbiology; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D010920:Placenta / Q000382:microbiology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000276:immunology* / Q000517:prevention & control; D012137:Respiratory System / Q000382:microbiology; D012409:Rubella / Q000276:immunology* / Q000382:microbiology / Q000517:prevention & control; D012411:Rubella Vaccine / Q000009:adverse effects*; D012412:Rubella virus / Q000276:immunology / Q000302:isolation & purification; D013997:Time Factors; D014611:Vaccination
D000914:Antibodies, Viral; D012411:Rubella Vaccine